Biotechnology Progress

Papers
(The H4-Index of Biotechnology Progress is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Proteomics‐based method to comprehensively model the removal of host cell protein impurities76
Issue Information55
Pre‐folding purification procedures for inclusion body‐derived non‐tagged cationic recombinant proteins with multiple disulfide bonds for efficient refolding46
Dynamic pH profiles drive higher cell‐specific and volumetric productivity45
Exploring the design space for T riton X ‐100 substitutes in viral inactivation applications42
Acetate accumulation and regulation by process parameters control in Chinese hamster ovary cell culture28
Optimized pulse‐feeding fed‐batch fermentation for enhanced lignin to polyhydroxyalkanoate transformation26
Depth filtration for clarification of intensified lentiviral vector suspension cell culture24
Dynamic flux balance analysis of 1,3‐propanediol production by clostridium butyricum fermentation24
From protein structure to an optimized chromatographic capture step using multiscale modeling23
The effects of the chemical modification on immobilized lipase features are affected by the enzyme crowding in the support23
High‐yield recombinant adeno‐associated viral vector production by multivariate optimization of bioprocess and transfection conditions22
Removal of chromatin by salt‐tolerant endonucleases for production of recombinant measles virus21
The production of succinate with more CO 2 fixation reactions facilitate20
Online monitored characterization of Phocaeicola vulgatus for organic acid production using anaerobic microtiter plate cultivations19
Issue Information19
Enrichment of full AAV capsids by preparative strong anion exchange chromatography18
Evaluating multiproduct chromatography Protein A resin reuse for monoclonal antibodies in biopharmaceutical manufacturing17
Genetically engineered neural stem cells (NSCs) therapy for neurological diseases; state‐of‐the‐art17
Current status of platelet manufacturing in 3D or bioreactors17
0.18432903289795